About Human Genome Sciences (NASDAQ:HGSI)
Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products include BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. HGS continues to deliver raxibacumab to the United States Strategic National Stockpile (SNS) for emergency use in treating inhalation anthrax. In addition to the Company's internal pipeline, it has financial rights to two drugs that GlaxoSmithKline (GSK) has advanced to late-stage development. These include darapladib and albiglutide. A randomized Phase 2 trial is evaluating mapatumumab in combination with Nexavar (sorafenib) for the treatment of advanced hepatocellular cancer. The Company manufactures multiple protein and antibody drugs for use in research, clinical and commercial activities. It produces and purifies these protein and antibody drugs in three process development and manufacturing facilities. In August 2012, GlaxoSmithKline plc acquired HGS.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Human Genome Sciences (NASDAQ:HGSI) Frequently Asked Questions
What is Human Genome Sciences' stock symbol?
Human Genome Sciences trades on the NASDAQ under the ticker symbol "HGSI."
Who are some of Human Genome Sciences' key competitors?
Some companies that are related to Human Genome Sciences include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Eli Lilly and (LLY), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Sanofi (SAN), Bayer (BAYN) and Celgene (CELG).
How do I buy Human Genome Sciences stock?
Shares of Human Genome Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Human Genome Sciences?
Human Genome Sciences' mailing address is 14200 Shady Grove Rd, ROCKVILLE, MD 20850-7464, United States. The biopharmaceutical company can be reached via phone at +1-301-3098504.
MarketBeat Community Rating for Human Genome Sciences (HGSI)MarketBeat's community ratings are surveys of what our community members think about Human Genome Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Human Genome Sciences (NASDAQ:HGSI) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Human Genome Sciences (NASDAQ:HGSI) Earnings History and Estimates Chart
Human Genome Sciences (NASDAQ HGSI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Human Genome Sciences (NASDAQ:HGSI) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Human Genome Sciences (NASDAQ:HGSI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Human Genome Sciences (NASDAQ HGSI)
No insider trades for this company have been tracked by MarketBeat.com
Human Genome Sciences (NASDAQ HGSI) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Human Genome Sciences (NASDAQ:HGSI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Human Genome Sciences (NASDAQ:HGSI) Income Statement, Balance Sheet and Cash Flow Statement
Human Genome Sciences (NASDAQ HGSI) Stock Chart for Saturday, February, 24, 2018